BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

  January 7, 2026

   · 

  3 min read
• Press Releases

  Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 7, 2026

   · 

  1 min read
• Press Releases

  BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs

  January 7, 2026

   · 

  11 min read
• Press Releases

  Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

  January 7, 2026

   · 

  8 min read
• Press Releases

  Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance

  January 7, 2026

   · 

  10 min read
• Press Releases

  Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

  January 7, 2026

   · 

  9 min read
• Press Releases

  BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

  January 7, 2026

   · 

  9 min read
• Press Releases

  Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week

  January 7, 2026

   · 

  5 min read
• Press Releases

  Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence

  January 7, 2026

   · 

  3 min read
• Press Releases

  Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

  January 7, 2026

   · 

  13 min read